Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial
2012 ◽
Vol 39
(9)
◽
pp. 761-769
◽
Keyword(s):
Phase 2
◽